I think James is saying here it’s yet another positive piece to complete the “jigsaw” and to get to the end result of packaging up all the data and stats and presenting it for fastrack sign off by the FDA. That’s a huge thing for Kazia and Paxalisib. Once that approval is obtained, the rest is history as I see it. It’s then a case of commercialisation, revenue and changing people’s lives.
- Forums
- ASX - By Stock
- Ann: Kazia presents PK data for paxalisib at AACR meeting
I think James is saying here it’s yet another positive piece to...
-
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online